Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.12
+0.04 (0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
5.12
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lifecore Biomedical stock has a target of 5.50, which predicts an increase of 7.42% from the current stock price of 5.12.
Analyst Consensus: Buy
* Price targets were last updated on Mar 27, 2026.
Analyst Ratings
The average analyst rating for Lifecore Biomedical stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $5.5 | Buy | Maintains | $5.5 | +7.42% | Mar 27, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $5.5 | Buy | Maintains | $5.5 | +7.42% | Mar 24, 2026 |
| Barrington Research | Barrington Research | Hold → Buy Upgrades $5.5 | Hold → Buy | Upgrades | $5.5 | +7.42% | Mar 17, 2026 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 4, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 21, 2025 |
Financial Forecast
Revenue This Year
124.88M
from 129.46M
Decreased by -3.54%
Revenue Next Year
131.17M
from 124.88M
Increased by 5.04%
EPS This Year
-0.91
from -0.93
EPS Next Year
-0.93
from -0.91
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 129.1M | 137.2M | |||||
| Avg | 124.9M | 131.2M | |||||
| Low | 119.4M | 122.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -0.3% | 9.9% | |||||
| Avg | -3.5% | 5.0% | |||||
| Low | -7.8% | -1.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.93 | -0.96 | |
| Avg | -0.91 | -0.93 | |
| Low | -0.87 | -0.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.